Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease

PURPOSE: This study aimed to evaluate the long-term efficacy and safety of infliximab (IFX) and cyclosporine (CsA) combination therapy for refractory uveoretinitis in Behçet’s disease (BD). PATIENTS AND METHODS: The study involved a retrospective review of the medical records of 11 patients with Beh...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsuyama, Atsuko, Kusuhara, Sentaro, Nishisho, Ryuto, Matsumiya, Wataru, Azumi, Atsushi, Nakamura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433110/
https://www.ncbi.nlm.nih.gov/pubmed/30962672
http://dx.doi.org/10.2147/OPTH.S198648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433110/
https://www.ncbi.nlm.nih.gov/pubmed/30962672
http://dx.doi.org/10.2147/OPTH.S198648

Ejemplares similares